SCHEMBL29552431

SCHEMBL29552431

CSc1ccc(Nc2cc(Cl)nnc2C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.48
▸ MEN1 O00255 5/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ GSK3B P49841 3/20 0.38
▸ CCNB2 O95067 1/20 0.38
▸ CCNE2 O96020 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ CCND1 P24385 1/20 0.38
▸ CCNE1 P24864 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359017 0.87 SYK (0.46) SYKMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL29922724 0.87 SYK (0.46) SYKMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL29551786 0.82 SYK (0.44) SYKMEN1KMT2AALDH1A1AKR1C3
SCHEMBL29551893 0.82 MEN1 (0.40) SYKMEN1KMT2AALDH1A1NPC1
SCHEMBL29552492 0.80 SYK (0.46) SYKMEN1KMT2AMAPTNPC1
SCHEMBL29551896 0.78 EHMT2 (0.47) SYKMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL29552554 0.78 HTR2C (0.40) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL29552110 0.78 JAK2 (0.55) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL29551959 0.77 JAK2 (0.46) MAPTKDM1A
SCHEMBL29553126 0.74 SYK (0.41) SYKMEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback